All Roll Calls
Yes: 171 • No: 6
MarylandSB 07782026 Regular SessionSenateWALLET
Clinical Research Pharmacies and Clinical Trials - Permits and Ownership
Sponsored By: Brian J. Feldman (Democratic)
Signed by Governor
Health OccupationsApplicants and ApplicationsClassifications and DesignationsCommittees and CommissionsComplaintsDrugs -see also- Cannabis; ControlDangSubst; Pharm; etc.EthicsHealth Occupations -see also- (specific health occupations)Inspections -see also- Motor Vehicle InspectionInvestigations and Inquiries -see also- Crim Bckgrnd InvestLicenses -see also- AB Lic; Certifications; DrLic; PermitsMedical ResearchPermits -see also- Building PermitsPharmacists and Pharmacies -see also- DrugsRules and RegulationsSafety -see also- Occupational SafetyStandards and Best PracticesStorage
Your PRIA Score
Score Hidden
Personalized for You
How does this bill affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
4 provisions identified: 1 benefits, 2 costs, 1 mixed.
Companies can run clinical trials
Beginning October 1, 2026, a company that runs a registered clinical trial is not practicing medicine if it meets three rules. The trial must follow registered FDA, EMA, or similar protocols and ethics rules. Licensed individuals must make all medical decisions, and the company must not provide general medical care outside the trial.
New permit for research pharmacies
Beginning October 1, 2026, you must have a clinical research pharmacy permit to establish or run one. Each site needs its own permit. The Board only issues permits to pharmacies that operate under IRB‑approved research protocols that meet FDA or similar standards, are not open to the public, and dispense only to trial participants. Pharmacies must follow USP security and storage rules and any other Board requirements. The Board adopts regulations for standards, applications, inspections, and discipline.
Ownership rules for research pharmacies
Beginning October 1, 2026, licensed providers and others can own part of a clinical research pharmacy. A Maryland‑licensed pharmacist must be on‑site during all hours and oversee compounding and dispensing. Owners with a substantial stake may not steer patients to one pharmacist or get paid for referrals. Those owners may not serve as a clinical investigator for that pharmacy’s trials and may not override a pharmacist’s judgment. The Board may not discipline a nonlicensed owner based only on ownership.
Boards can probe unlicensed staff
Beginning October 1, 2026, health occupations boards can investigate claims that a clinical research pharmacy worker practices without a required license or with an unauthorized person. Boards can also investigate alleged violations under their rules for that profession.
Free Policy Watch
You just read the policy. Now see what it costs you.
Pick a topic. PRIA runs your household against live legislation and sends you a free personalized readout.
Pick a topic to get started
Sponsors & Cosponsors
Sponsor
Brian J. Feldman
Democratic • Senate
Cosponsors
There are no cosponsors for this bill.
Roll Call Votes
House vote • 4/13/2026
Third Reading Passed
Yes: 129 • No: 6 • Other: 6
Senate vote • 3/20/2026
Third Reading Passed
Yes: 42 • No: 0 • Other: 4
Actions Timeline
Approved by the Governor - Chapter 206
4/28/2026Returned Passed
4/13/2026SenateThird Reading Passed (129-6)
4/13/2026HouseFavorable Adopted Second Reading Passed
4/11/2026HouseFavorable Report by Health
4/11/2026HouseHearing 4/02 at 1:00 p.m.
3/25/2026HouseReferred Health
3/21/2026HouseThird Reading Passed (42-0)
3/20/2026SenateSecond Reading Passed with Amendments
3/19/2026SenateFavorable with Amendments {993324/1 Adopted
3/19/2026SenateFavorable with Amendments Report by Finance
3/19/2026SenateHearing 3/03 at 1:00 p.m.
2/12/2026SenateFirst Reading Finance
2/6/2026Senate
Bill Text
Third Reading
3/19/2026
First Reading
2/6/2026
Related Bills
SB 1007 — Prior Authorizations of State Debt - Alterations
SB 0940 — Environment - Water Quality Testing - Secondary Maximum Contaminant Levels Action Plan
SB 0915 — State Board of Physicians - Delegation of Duties - Alterations
SB 0777 — Labor and Employment - Workforce Development - Hospital Employee Retraining and Placement Program and Workforce Development and Local Workforce Development Boards (Local Workforce Solutions Investment Act)
SB 0772 — Maryland Department of Health - Employment Training and Opportunity Database
SB 0742 — Maryland Medical Assistance Program and Developmental Disabilities Administration - Home- and Community-Based Services Eligibility Determinations (Maryland Protecting People With Disabilities Act)
Take It Personal
Get Your Personalized Policy View
Take the PRIA Score to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in